Clinical trial
Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic…
NCT00174434 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00174434 |
|---|---|
| Title | Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer |
| Official title | A Phase 1 Study Of Paclitaxel In Combination With SU011248 For Patients With Breast Cancer As First-Line Treatment In The Advanced Disease Setting |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | SU011248, Paclitaxel |
| Enrollment | 22 |
| Start date | Sep 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 27, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: